Cooper Companies (NYSE:COO) updated its FY20 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $12.60-13.00 for the period, compared to the Thomson Reuters consensus estimate of $13.08. The company issued revenue guidance of $2.767-2.817 billion, compared to the consensus revenue estimate of $2.82 billion.Cooper Companies also updated its Q1 guidance to $2.65-2.75 EPS.
COO stock traded up $0.77 during mid-day trading on Thursday, hitting $312.86. The company had a trading volume of 327,300 shares, compared to its average volume of 319,514. The firm has a market cap of $15.47 billion, a PE ratio of 27.21, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.73 and a current ratio of 1.29. Cooper Companies has a 12 month low of $228.65 and a 12 month high of $344.32. The stock’s fifty day moving average price is $297.98 and its two-hundred day moving average price is $311.99.
A number of research firms recently commented on COO. KeyCorp lifted their price target on shares of Cooper Companies from $348.00 to $351.00 and gave the stock an overweight rating in a report on Wednesday, November 27th. Jefferies Financial Group dropped their price objective on Cooper Companies from $358.00 to $330.00 and set an in-line rating on the stock in a research note on Wednesday. ValuEngine lowered Cooper Companies from a buy rating to a hold rating in a report on Tuesday, September 10th. Zacks Investment Research raised Cooper Companies from a sell rating to a hold rating and set a $325.00 target price for the company in a research report on Wednesday, November 20th. Finally, Wells Fargo & Co boosted their target price on Cooper Companies from $356.00 to $365.00 and gave the company an outperform rating in a research note on Thursday, August 8th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the company. The company presently has a consensus rating of Buy and an average price target of $325.27.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Further Reading: Consumer behavior in bull markets
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.